Discontinued — last reported Q4 '20
EMCOR Group Business Sale Proceeds remained flat by 0.0% to $64.16M in Q4 2025 compared to the prior quarter.
An increase signals portfolio optimization or a strategic pivot, while a lack of proceeds suggests a stable, long-term asset base.
This metric represents the cash inflows received from the divestiture or sale of business segments, product lines, or su...
Occurs sporadically; peers often divest legacy segments to focus on high-margin innovation areas like continuous glucose monitoring or diagnostics.
proceeds_from_sale_of_business| FY'23 | FY'24 | FY'25 | |
|---|---|---|---|
| Value | $0.00 | $0.00 | $256.62M |